2022
United States Emergency Department Screening for Drug Use Among Assault-Injured Individuals: A Systematic Review
Coupet E, Dodington J, Brackett A, Vaca FE. United States Emergency Department Screening for Drug Use Among Assault-Injured Individuals: A Systematic Review. Western Journal Of Emergency Medicine 2022, 23: 443-450. PMID: 35980419, PMCID: PMC9391011, DOI: 10.5811/westjem.2022.5.55475.Peer-Reviewed Original ResearchConceptsDrug useSystematic reviewNon-duplicated studiesModifiable risk factorsEmergency Department ScreeningEmergency department settingBusy emergency department settingMeta-analysis protocolMedical Subject Headings termsPreferred Reporting ItemsSubject Headings termsFull-text articlesOvid AMEDTreatment initiationCochrane CENTRALOvid EmbaseDirect referralRisk factorsDepartment settingPharmacological interventionsCommon drugsReporting ItemsTreatment servicesClinical modelScreen questions
2020
Executive summary from American Radium Society’s appropriate use criteria on neurocognition after stereotactic radiosurgery for multiple brain metastases
Milano MT, Chiang VLS, Soltys SG, Wang TJC, Lo SS, Brackett A, Nagpal S, Chao S, Garg AK, Jabbari S, Halasz LM, Gephart MH, Knisely JPS, Sahgal A, Chang EL. Executive summary from American Radium Society’s appropriate use criteria on neurocognition after stereotactic radiosurgery for multiple brain metastases. Neuro-Oncology 2020, 22: 1728-1741. PMID: 32780818, PMCID: PMC7746939, DOI: 10.1093/neuonc/noaa192.Peer-Reviewed Original ResearchMeSH KeywordsBrain NeoplasmsCranial IrradiationHumansRadiosurgeryRadiumSystematic Reviews as TopicUnited StatesConceptsWhole brain radiotherapyAsymptomatic brain metastasesGood performance statusBrain metastasesMultiple brain metastasesAppropriate use criteriaStereotactic radiosurgeryPerformance statusTreatment optionsAmerican Radium Society Appropriate Use CriteriaHippocampal Sparing-Whole Brain RadiotherapySystematic reviewConventional whole brain radiotherapySingle-fraction stereotactic radiosurgeryProgressive extracranial diseasePoor performance statusAppropriate treatment optionsQuality of evidenceBrainstem metastasesExtracranial diseaseConsensus guidelinesOptimal treatmentSystemic optionsNeurocognitive outcomesPatients